4.7 Review

Sexual Dimorphism of Corticosteroid Signaling during Kidney Development

Journal

Publisher

MDPI
DOI: 10.3390/ijms22105275

Keywords

aldosterone; cortisol; mineralocorticoid and glucocorticoid receptors; neonates; kidney; development; sexual dimorphism

Funding

  1. French National Institute for Health and Medical Research (Inserm)
  2. Paris-Saclay University
  3. French National Agency for Research (ANR) [ANR-20-CE14-0015]
  4. Ministry of Health as part of the 3rd National Plan for Rare Diseases (2018-2022)

Ask authors/readers for more resources

Sexual dimorphism involves differences between biological sexes beyond sexual characteristics, impacting biological processes such as blood pressure and predisposition to develop hypertension. Recent studies suggest distinct tissue-specific expression and regulation of corticosteroid signaling pathways in a sex-dependent manner, particularly in the kidney, which may have significant physiological implications.
Sexual dimorphism involves differences between biological sexes that go beyond sexual characteristics. In mammals, differences between sexes have been demonstrated regarding various biological processes, including blood pressure and predisposition to develop hypertension early in adulthood, which may rely on early events during development and in the neonatal period. Recent studies suggest that corticosteroid signaling pathways (comprising glucocorticoid and mineralocorticoid signaling pathways) have distinct tissue-specific expression and regulation during this specific temporal window in a sex-dependent manner, most notably in the kidney. This review outlines the evidence for a gender differential expression and activation of renal corticosteroid signaling pathways in the mammalian fetus and neonate, from mouse to human, that may favor mineralocorticoid signaling in females and glucocorticoid signaling in males. Determining the effects of such differences may shed light on short term and long term pathophysiological consequences, markedly for males.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency

Eric Pussard, Simon Travers, Claire Bouvattier, Qiong-Yao Xue, Claudine Cosson, Say Viengchareun, Laetitia Martinerie, Marc Lombes

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Article Endocrinology & Metabolism

Interaction between accumulated 21-deoxysteroids and mineralocorticoid signaling in 21-hydroxylase deficiency

Simon Travers, Claire Bouvattier, Jerome Fagart, Laetitia Martinerie, Say Viengchareun, Eric Pussard, Marc Lombes

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)

Article Biochemistry & Molecular Biology

Preterm birth is associated with epigenetic programming of transgenerational hypertension in mice

Laurence Dumeige, Melanie Nehlich, Say Viengchareun, Julie Perrot, Eric Pussard, Marc Lombes, Laetitia Martinerie

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells

Florian Le Billan, Julie Perrot, Elena Carceller, Simon Travers, Say Viengchareun, Peter Kolkhof, Marc Lombes, Jerome Fagart

Summary: The study analyzed the effects of two MRAs on the aldosterone-induced transcriptome in a human renal cell line, revealing the regulation of hundreds of genes by aldosterone and the quantitative efficiency of finerenone on certain aldosterone-induced genes. The data provides insights into the mechanisms of MR signaling pathway and potential therapeutic targets for renal dysfunction.

FASEB JOURNAL (2021)

Article Biochemistry & Molecular Biology

Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium

Jeremie Canonica, Min Zhao, Tatiana Favez, Emmanuelle Gelize, Laurent Jonet, Laura Kowalczuk, Justine Guegan, Damien Le Menuet, Say Viengchareun, Marc Lombes, Eric Pussard, Yvan Arsenijevic, Francine Behar-Cohen

Summary: Glucocorticoids are commonly used drugs to treat retinal diseases, but the transcriptional regulations induced by GR and MR activation in RPE cells are not well understood. The study found that in the human eye, cortisol is the main ligand for GR and MR, and genes regulated by aldosterone and cortisol + RU-486 can mimic an imbalance toward MR activation. This activation in RPE cells may contribute to retinal pathology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

The invention of aldosterone, how the past resurfaces in pediatric endocrinology

Say Viengchareun, Eric Pussard, Mireille Castanet, Laurent M. Sachs, Thi An Vu, Pascal Boileau, Marc Lombes, Laetitia Martinerie

Summary: At birth, mammals transition from aquatic to terrestrial life, leading to significant changes in sodium and water homeostasis. The mineralocorticoid signaling pathway plays a crucial role during this critical developmental period, with aldosterone likely being one of the main hormones regulating this transition.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Article Cell Biology

miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under Hypertonicity

Thi An Vu, Ingrid Lema, Imene Hani, Lydie Cheval, Laura Atger-Lallier, Vilayvane Souvannarath, Julie Perrot, Melanie Souvanheuane, Yannick Marie, Sylvie Fabrega, Anne Blanchard, Jerome Bouligand, Peter Kamenicky, Gilles Crambert, Laetitia Martinerie, Marc Lombes, Say Viengchareun

Summary: Under hypertonicity, miR-324-5p and miR-30c-2-3p are recruited to regulate MR expression and signaling, affecting renal function and sodium retention.

CELLS (2022)

Article Peripheral Vascular Disease

Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats

Ly Tu, Raphael Thuillet, Julie Perrot, Mina Ottaviani, Emy Ponsardin, Peter Kolkhof, Marc Humbert, Say Viengchareun, Marc Lombes, Christophe Guignabert

Summary: Research showed that MR is overexpressed in preclinical models and human PAH, with inhibition by finerenone attenuating proliferation of pulmonary artery smooth muscle cells and partially reversing established pulmonary hypertension. The treatment also reduced total pulmonary vascular resistance and vascular remodeling, as well as decreasing inflammatory cell infiltration and vascular cell proliferation in rat lungs. This suggests that finerenone could be a potential therapy for PAH, warranting further investigation for clinical use alongside current treatments.

HYPERTENSION (2022)

Article Biochemistry & Molecular Biology

The mineralocorticoid receptor modulates timing and location of genomic binding by glucocorticoid receptor in response to synthetic glucocorticoids in keratinocytes

Elena Carceller-Zazo, Lisa M. Sevilla, Omar Pons-Alonso, Alvaro Chiner-Oms, Larbi Amazit, Thi An Vu, Geraldine Vitellius, Say Viengchareun, Inaki Comas, Yan Jaszczyszyn, Montserrat Abella, Andrea Alegre-Marti, Eva Estebanez-Perpina, Marc Lombes, Paloma Perez

Summary: Glucocorticoids exert therapeutic effects on skin diseases through binding to the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). The MR has an impact on the genomic binding and transcriptional response of GR, affecting the specificity and magnitude of gene expression in keratinocytes.

FASEB JOURNAL (2023)

No Data Available